COA president addresses brand misuse and false claims

“We want to assure our customers and stakeholders that we are taking concrete steps to address this issue. We are working closely with the relevant authorities to ensure that our brand is protected, and our customers are not misled.”

The President General of COA Research and Manufacturing Limited Company, Professor Samuel Ato Duncan has called on the general public to be worried about adverts and other false claims that COA products serve as a cure for HIV/AIDS and others.

According to him, the COA products were formulated to promote general well-being.

Speaking at a Press Conference in Accra to address the issues, Prof. Duncan said the primary objective of the event was to provide a clear and accurate issue on the misuse of the COA brand including, price variation of COA products and the differences between COA Plus and COA Mixture.

“Whether the individual is feeling under the weather or simply seeking to maintain optimal health, COA Mixture can be a daily companion. It supports a healthy body by assisting with natural recovery processes and fostering optimal bodily functions”.

Prof. Duncan revealed further that, for those seeking a powerful immune system boost, COA Plus Mixture is the answer added that, the innovative formula specifically targets the body’s natural defense mechanisms.

“COA Plus Mixture supports the body’s immunity, empowering the body to fight off infections and illnesses”.

Given their distinct purposes, he recommended using only COA Mixture or COA Plus Mixture at a time to maximise its effectiveness.

“We’ve recently discovered unauthorized marketing materials falsely promoting COA Mixture and COA Plus Mixture as cures for various diseases, including cancer, kidney disease, and HIV/AIDS. It’s crucial to understand”.

According to Prof. Samuel Ato Duncan, COA Mixture and COA Plus Mixture are not registered for cures saying, they are not only a violation of FDA advertising regulations but, also limit the true potential of the products.

“Their purpose is to support your well-being, not replace traditional medical treatment for serious illnesses”.

COA MT Mixture he hinted, specifically formulated to address malaria, offers a different pricing perspective. “Made with Neem, it’s a tasteless product with a slightly pungent aroma due to the rigorous extraction process used to isolate the active ingredients. We’ve intentionally retained this aroma, believing it holds additional therapeutic properties”.

He emphasized that, since the introduction late last year, COA MT Mixture has maintained a consistent retail price of GHS50.

“We understand that some consumers have raised concerns about the pricing of COA products. Let’s delve into the factors at play”.

Prof. Duncan pledged on behalf of management to provide consumers with precise details and guarantee responsible use of their products.

“Distributors who wish to develop advert materials should kindly contact our Public Relations Department for the needed guidance and support”

He said choosing the right COA product can be a breeze when customers understand their distinct strengths.

He urged their valued customers, to be wary of such misleading claims. “Don’t be deceived by these ploys. COA Mixture, produced with the utmost care and the strictest quality controls, is readily available through authorized distributors”.

On her part, the Deputy Chief Executive Officer of the Company, Lady Princess Duncan said COA Research and Manufacturing Limited Company is committed to providing high-quality products and excellent customer service.

She said over the years, we have built our reputation on trust, innovation, and customer satisfaction.

This, she added was achieved through the media’s continuous support.

“We want to assure our customers and stakeholders that we are taking concrete steps to address this issue. We are working closely with the relevant authorities to ensure that our brand is protected, and our customers are not misled.”

COACOA MixtureCOA PlusCOA Research and Manufacturing Limited CompanycureHIV/AIDSmanufacturingProfessor Samuel Ato Duncanresearch